Articles in Category: More News

A publication from 2023 researching Fabry disease, pharm-analyt involved

News from Sunday, 01 December 2024.

Comparison of efficacy between subcutaneous and intravenous application of moss-aGal in the mouse model of Fabry disease, co-author Daniel Mascher, Gb3 and lyso Gb-3

Download PDF

Refining the Overall Strategy after 38 Years

News from Saturday, 15 June 2024.

pharm-analyt Working on its Key Account and Overall Strategy: A process having started on 3 April 2024 with an external consultant will be concluded by 30 November 2024

Meet our Founder @ World Orphan Drug Congress in Boston

News from Monday, 08 April 2024.

World Orphan Drug Congress in the USA: 23.04.2024-25.04.2024

Meet one of our GMP QPs @ Analytica in München

News from Monday, 25 March 2024.

Analytica in Germany: 09.04.2024-12.04.2024

Meet our Founder @ 14th PBP World Meeting in Vienna

News from Wednesday, 14 February 2024.

World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology in Austria: 18.03.-21.03.2024

12 3 4 5 »Last

Did you know:

We work, where the

Austrian Emperors

went on vacation.

(Historical town of Baden)
Every day

we are learning something
about bioanalysis.
We are

always eager
for difficult analytical challenges.
Our most sensitive method has an LLOQ of

0.00000000000025

g/mL plasma.

= 250 femtogram/mL
or 250 x 10^-15 g/mL
or 1 kg sugar in lake Chiemsee!
A quote from one of our collaborators concerning PEG tissue analysis: I am totally blown away by the fact that not only do you have measurable levels of PEG

but they are also dose-dependent!!

Amazing stuff!!
pharm-analyt has won

several awards

for innovation.
We are

locals

in the area of trace analysis.
Our first look might be

invaluable

and it’s for free!
"Never give in,
never, never
never, never, in nothing great or small."
(Sir Winston Churchill)
pharm-analyt was founded

long before

mass spec was widespread.
pharm-analyt is

fully family-owned.
pharm-analyt has sold

3 European patents

on biomarkers.
pharm-analyt conducts

25

(bio)-analytical feasibility
studies each year.
Metabolite profiling is a matter of

a few days,

not months.
Rumors say:

…Of all of our equipment, the
highest throughput is with our

espresso machine?!
pharm-analyt was

one of the first

CROs to switch to electronic archiving.
A part of our historical
premises used to be a

bakery

before we moved in.
pharm-analyt has developed bioanalytical assays for more than

400 compounds.
pharm-analyt requires as little as

50 µL

sample volume for clinical studies,
if necessary.
In a number of cases chemical

derivatization

might be the key to
success in bioanalysis.
Throughout the

35 years

of pharm-analyt’s existence it
was always equipped with
state-of-the-art instrumentation.
Inpassible…? Imposibol…? Unpossibal…?

Sorry, we’re just not
familiar with this word.
pharm-analyt has discovered biomarkers that will save

the lives of thousands of children

suffering from various rare diseases.
You will get the clinical PK profile of

250

common drugs from us for free.

Contact us.
pharm-analyt has been
GLP certified for almost

30 years.
50 %

of the analytical know-how lies
in sample preparation.
Why our founder’s

hairstyle

sometimes reminds of a well known nuclear physicist? Tell us if you know!
They say

it’s not feasible?

Give us a try.
We are

giving away

a lot of our know-how in Hermann’s book “HPLC Methods for Clinical Pharmaceutical Analysis”.

(See R&D)
pharm-analyt has developed
multiple ways of

stabilizing peptides

in plasma.
Rumors say:

…For a remarkable bottle of

Chardonnay,

our founder Hermann Mascher would conduct the analysis of a large clinical study for free. :-)
“Edelweiss”

is not the Austrian anthem.
It is our national flower.
pharm-analyt has over

100 publications

in peer reviewed journals.

›

‹

Articles in Category: More News

Austrian Emperors

Every day

always eager

0.00000000000025

but they are also dose-dependent!!

several awards

locals

invaluable

never, never

long before

fully family-owned.

3 European patents

25

a few days,

espresso machine?!

one of the first

bakery

400 compounds.

50 µL

derivatization

35 years

Inpassible…? Imposibol…? Unpossibal…?

the lives of thousands of children

250

30 years.

50 %

hairstyle

it’s not feasible?

giving away

stabilizing peptides

Chardonnay,

“Edelweiss”

100 publications